A Study to Explore the Effect of Acid-reducing Agents
Completed · Phase 1
Conditions studied: Healthy Adults
In brief
A Phase 1 Study of the Effect of Acid-reducing Agents on the Pharmacokinetics of a Single Oral Dose of Sitravatinib in Healthy Adult Subjects. The study is a single-center, open-label, 2-period, 2-treatment, fixed-sequence crossover, parallel-group study.
Key facts
- Study ID
- NCT04935112
- Run by
- Mirati Therapeutics Inc.
- People needed
- 15
- Starts
- 2021-07-07
- Expected to finish
- 2022-07-12
- Last updated by the study team
- 2022-08-26
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Covance Clinical Research Unit Inc. — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.